Bcl-2 expression in breast carcinoma cells in vitro

Abstract

Author(s): Jolanta Rzymowska

Apoptosis is a physiological form of cell death that occurs in all tissues Deregulated expression of some oncogenes causes increased cell division and advances cell growth. The balance between bcl-2 and c-myc and c-jun seems to be an important determinant of cellular sensitivity to the induction of apoptosis. Bcl-2 gene promotes cell survival rather than cell proliferation In the our study bcl-2 has been demonstrated to inhibit apoptosis in breast cancer cells in vitro (T47D). High expression of bcl-2 was noticed to be strongly related to low rates of apoptotic and necrotic cell death. The mean value of the apoptotic index was 7.5% in bcl-2-negative tumours and 0.55% in bcl-2-positive tumours. High proliferation rate was associated with the absence of bcl-2 expression. C-myc and c-jun accumulation were associated with the presence of bcl- 2 expression and with decreased apoptotic activity. The loss of bcl-2 expression was strongly correlated with increased apoptotic and necrotic cell death. This establishes a model in which bcl-2 not only mediates in cell death, but also cell division in breast carcinoma cells, and in which the regulation of cell division and cell death are strictly connected.

Share this article

Editors List

  • Andrzej Zdziennicki

    Institute of Gynecology and Obstetrics, Medical University of Lodz, I Clinic of Gynecology and Gynecological Oncology (Lodz, Poland)

  • Krzysztof Urbanski

    Head of the Oncology Gynecology Clinic, Oncology Center - Instytut im. Maria Sklodowska Curie, Department in Krakow (Krakow, Poland)

  • Andrzej Szawlowski

    Klinika Nowotworow Gornego Odcinka Uklad Digestii, Oncology Center - Institute (Warsaw, Poland)

  • Skowronska-Gardas

    Department of Radiotherapy, Oncology Center-Institute (Warsaw, Poland)

  • Serban-Dan Costa

    Head of the Obstetrics and Gynecology Clinic of the University of Otto von Guericke (Magdeburg, Germany)